Lonnel Coats
Chief Executive Officer, Lexicon Pharmaceuticals.
Companies
- Relay TherapeuticsBoard member Nov 6, 2025 to now1
- Verve Therapeutics, Inc.Board member Aug 9, 2022 to now2
- Blueprint Medicines CorpBoard member Feb 5, 2016 to now3
- Lexicon PharmaceuticalsBoard member Jul 8, 2014 to Feb 29, 20244
- Lexicon PharmaceuticalsChief executive officer Jul 8, 2014 to Feb 29, 20244
- Lexicon PharmaceuticalsPresident Jul 8, 2014 to Mar 2, 20214
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexicon Pharmaceuticals LXRX1,098,068 shares5$1.7M at $1.56Feb 28, 2024
- Blueprint Medicines Corp0 shares6Jul 17, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 17, 2025Returned to company 6,144 shares of Blueprint Medicines Corp6
- Jun 18, 2025Granted 3,902 shares at $12,812.00 of Blueprint Medicines Corp7
- Nov 21, 2024Sold 9,824 shares at $94.87 of Blueprint Medicines Corp8
- Nov 20, 2024Sold 213 shares at $94.99 of Blueprint Medicines Corp8
- Nov 20, 2024Sold 5,287 shares at $94.24 of Blueprint Medicines Corp8
- Nov 20, 2024Sold 4,500 shares at $93.15 of Blueprint Medicines Corp8
- Nov 20, 2024Exercised options 1,312 shares at $76.24 of Blueprint Medicines Corp8
- Nov 20, 2024Exercised options 7,500 shares at $69.79 of Blueprint Medicines Corp8
- Jun 12, 2024Granted 2,242 shares of Blueprint Medicines Corp9
- Feb 28, 2024Shares withheld for tax 61,371 shares at $2.62 of Lexicon Pharmaceuticals5
- Feb 28, 2024Exercised options 120,383 shares of Lexicon Pharmaceuticals5
- Feb 28, 2024Exercised options 91,364 shares of Lexicon Pharmaceuticals5
- Feb 28, 2024Exercised options 33,333 shares of Lexicon Pharmaceuticals5
- Nov 16, 2023Bought 90,000 shares at $1.05 of Lexicon Pharmaceuticals10
- Nov 10, 2023Bought 10,000 shares at $1.01 of Lexicon Pharmaceuticals11
- Jun 29, 2023Bought 10,000 shares at $2.16 of Lexicon Pharmaceuticals12
- Jun 26, 2023Bought 10,000 shares at $2.18 of Lexicon Pharmaceuticals13
- Jun 23, 2023Bought 10,000 shares at $2.50 of Lexicon Pharmaceuticals13
- Jun 22, 2023Bought 40,000 shares at $2.31 of Lexicon Pharmaceuticals14
- Jun 21, 2023Granted 2,600 shares of Blueprint Medicines Corp15
- Feb 28, 2023Shares withheld for tax 50,971 shares at $2.17 of Lexicon Pharmaceuticals16
- Feb 28, 2023Exercised options 91,363 shares of Lexicon Pharmaceuticals16
- Feb 28, 2023Exercised options 33,334 shares of Lexicon Pharmaceuticals16
- Feb 28, 2023Exercised options 84,630 shares of Lexicon Pharmaceuticals16
- Jun 21, 2022Granted 2,600 shares of Blueprint Medicines Corp17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRelay Therapeutics, Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Jun 24, 2025
- 8SEC EDGARForm 4 filed Nov 22, 2024
- 9SEC EDGARForm 4 filed Jun 14, 2024
- 10SEC EDGARForm 4 filed Nov 17, 2023
- 11SEC EDGARForm 4 filed Nov 13, 2023
- 12SEC EDGARForm 4 filed Jun 29, 2023
- 13SEC EDGARForm 4 filed Jun 26, 2023
- 14SEC EDGARForm 4 filed Jun 22, 2023
- 15SEC EDGARForm 4 filed Jun 23, 2023
- 16SEC EDGARForm 4 filed Mar 1, 2023
- 17SEC EDGARForm 4 filed Jun 30, 2022